Pharmacokinetics, Pharmacodynamics, Safety and Tolerability Evaluation of CTAP101 Extended-release Capsules in Pediatric Participants

Clinical trial NCT07494045 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07494045
Sponsor: OPKO Health, Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

CKD Stage 3 CKD Stage 4 Secondary Hyperparathyroidism VDI

Start date: 2026-06-01
Primary completion: 2027-10-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.